Laminin increases the release of type IV collagenase from malignant cells.
We have studied the effect of laminin on type IV collagenolytic activity elaborated by malignant cells in culture. Laminin (at concentrations of 4-8 micrograms/ml) added to serum-free culture supernatants of subconfluent A2058 human melanoma cells significantly increased the release of the type IV collagenolytic activity (200-300%). The induction of type IV collagenase was more pronounced (580%) using a fragment of laminin which binds to the cell surface laminin receptor. A monoclonal antibody against the human laminin receptor blocked the effect of laminin on type IV collagenase, suggesting that occupation of the laminin receptor may be necessary for the effect. Increase in the type IV collagenolytic activity mediated by laminin was also demonstrated in two other malignant cell lines, HT fibrosarcoma (168%) and mouse melanoma (B16-F10) (271%). The increase in type IV collagenase was found to be specific for laminin because another cell-binding matrix protein, fibronectin, did not have any effect, and epidermal growth factor and transferrin actually decreased the type IV collagenase in human melanoma culture medium (epidermal growth factor, 50% at 20 ng/ml; and transferrin, 20% at 10 micrograms/ml). These studies suggest that tumor cell binding to laminin, which comprises the first step of basement membrane invasion, will induce the second step, namely the collagenolytic dissolution of the basement membrane.
D000818:Animals; D000911:Antibodies, Monoclonal; D002478:Cells, Cultured; D004815:Epidermal Growth Factor / Q000494:pharmacology; D005353:Fibronectins / Q000494:pharmacology; D005354:Fibrosarcoma / Q000201:enzymology / Q000378:metabolism*; D006801:Humans; D007797:Laminin / Q000494:pharmacology*; D008545:Melanoma / Q000201:enzymology / Q000378:metabolism*; D051379:Mice; D003012:Microbial Collagenase / Q000378:metabolism*; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000378:metabolism*; D010446:Peptide Fragments / Q000494:pharmacology; D011971:Receptors, Immunologic / Q000276:immunology / Q000378:metabolism; D017474:Receptors, Laminin; D012636:Secretory Rate / Q000187:drug effects; D014168:Transferrin / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D005353:Fibronectins; D007797:Laminin; D009363:Neoplasm Proteins; D010446:Peptide Fragments; D011971:Receptors, Immunologic; D017474:Receptors, Laminin; D014168:Transferrin; D004815:Epidermal Growth Factor; D003012:Microbial Collagenase